| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 11/01/2019 | 3. Issuer Name and Ticker or Trading Symbol Medtronic plc [ MDT ] | |||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Ordinary Shares | 13,075(1) | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Option (Right to Buy) | 10/28/2020(2) | 10/28/2029 | Ordinary Shares | 22,579 | 106.22 | D | |
| Stock Option (Right to Buy) | 08/03/2016(2) | 08/03/2025 | Ordinary Shares | 11,154 | 78 | D | |
| Stock Option (Right to Buy) | 08/03/2016(2) | 08/03/2025 | Ordinary Shares | 1,283 | 78 | D | |
| Stock Option (Right to Buy) | 08/01/2017(2) | 08/01/2026 | Ordinary Shares | 11,356 | 88.06 | D | |
| Stock Option (Right to Buy) | 08/01/2017(2) | 08/01/2026 | Ordinary Shares | 1,136 | 88.06 | D | |
| Stock Option (Right to Buy) | 07/31/2018(2) | 07/31/2027 | Ordinary Shares | 11,910 | 83.97 | D | |
| Stock Option (Right to Buy) | 07/31/2018(2) | 07/31/2027 | Ordinary Shares | 1,191 | 83.97 | D | |
| Stock Option (Right to Buy) | 07/30/2019(2) | 07/30/2028 | Ordinary Shares | 16,946 | 89.08 | D | |
| Stock Option (Right to Buy) | 07/30/2019(2) | 07/30/2028 | Ordinary Shares | 1,695 | 89.08 | D | |
| Stock Option (Right to Buy) | 07/29/2020(2) | 07/29/2029 | Ordinary Shares | 24,223 | 103.26 | D | |
| Stock Option (Right to Buy) | 07/29/2020(2) | 07/29/2029 | Ordinary Shares | 1,615 | 103.26 | D | |
| Stock Option (Right to Buy) | 12/02/2014(2) | 12/01/2023 | Ordinary Shares | 12,300 | 47 | D | |
| Stock Option (Right to Buy) | 06/29/2018(3) | 01/27/2025 | Ordinary Shares | 8,018 | 74.84 | D | |
| Explanation of Responses: |
| 1. Includes grants of restricted stock units which vest on the listed date and for the listed number of shares if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth measured over the three most recently completed fiscal years exceeds a 3% cumulative compound annual growth rate (as determined by the Compensation Committee): (i) 3,129 restricted stock units that vest on 7/31/2020; (ii) 2,884 restricted stock units that vest on 7/30/2021; and (iii) 7,062 restricted stock units that vest on 7/29/2022. |
| 2. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |
| 3. This option became exercisable on June 29, 2018, subject to Medtronic plc's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018. |
| /s/ Perry F. Sekus, attorney-in-fact | 11/07/2019 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
